Get started
Artivion, Inc.Artivion, Inc.Artivion, Inc.

Artivion, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

AORT chart


Full chart

AORT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.02 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.32 USD
Net income (FY)
‪−13.34 M‬ USD
Revenue (FY)
‪388.54 M‬ USD
Shares float
‪39.78 M‬
Beta (1Y)
0.84

Employees


Employees (FY)
‪1.6 K‬
Change (1Y)
+100 +6.67%
Revenue / Employee (1Y)
‪242.84 K‬ USD
Net income / Employee (1Y)
‪−8.33 K‬ USD

About Artivion, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
James Patrick Mackin
Website
artivion.com
Headquarters
Kennesaw
Founded
1984
FIGI
BBG000BMLVJ6
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AORT news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AORT highest yielding bonds


CRY5217113
Artivion, Inc. 4.25% 01-JUL-2025
Yield to maturity
−19.07%
Maturity date
Jul 1, 2025

See all AORT bonds 


Check out other big names from the same industry as AORT.

Frequently Asked Questions


The current price of AORT is 24.04 USD — it has increased by 2.21% in the past 24 hours. Watch Artivion, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Artivion, Inc. stocks are traded under the ticker AORT.
AORT stock has risen by 3.55% compared to the previous week, the month change is a −4.36% fall, over the last year Artivion, Inc. has showed a 17.10% increase.
We've gathered analysts' opinions on Artivion, Inc. future price: according to them, AORT price has a max estimate of 35.00 USD and a min estimate of 30.00 USD. Watch AORT chart and read a more detailed Artivion, Inc. stock forecast: see what analysts think of Artivion, Inc. and suggest that you do with its stocks.
AORT reached its all-time high on Aug 2, 2001 with the price of 44.82 USD, and its all-time low was 1.40 USD and was reached on Aug 15, 2002. View more price dynamics on AORT chart.
See other stocks reaching their highest and lowest prices.
AORT stock is 2.16% volatile and has beta coefficient of 0.84. Track Artivion, Inc. stock price on the chart and check out the list of the most volatile stocks — is Artivion, Inc. there?
Today Artivion, Inc. has the market capitalization of ‪1.02 B‬, it has decreased by −1.88% over the last week.
Yes, you can track Artivion, Inc. financials in yearly and quarterly reports right on TradingView.
Artivion, Inc. is going to release the next earnings report on May 5, 2025. Keep track of upcoming events with our Earnings Calendar.
AORT earnings for the last quarter are −0.39 USD per share, whereas the estimation was −0.065 USD resulting in a −500.00% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about Artivion, Inc. earnings.
Artivion, Inc. revenue for the last quarter amounts to ‪97.31 M‬ USD, despite the estimated figure of ‪100.89 M‬ USD. In the next quarter, revenue is expected to reach ‪94.80 M‬ USD.
AORT net income for the last quarter is ‪−16.45 M‬ USD, while the quarter before that showed ‪−2.29 M‬ USD of net income which accounts for −620.04% change. Track more Artivion, Inc. financial stats to get the full picture.
No, AORT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has ‪1.6 K‬ employees. See our rating of the largest employees — is Artivion, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Artivion, Inc. EBITDA is ‪86.77 M‬ USD, and current EBITDA margin is 13.30%. See more stats in Artivion, Inc. financial statements.
Like other stocks, AORT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Artivion, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Artivion, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Artivion, Inc. stock shows the buy signal. See more of Artivion, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.